Literature DB >> 8662521

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization.

Y Sato1, M Roman, H Tighe, D Lee, M Corr, M D Nguyen, G J Silverman, M Lotz, D A Carson, E Raz.   

Abstract

Vaccination with naked DNA elicits cellular and humoral immune responses that have a T helper cell type 1 bias. However, plasmid vectors expressing large amounts of gene product do not necessarily induce immune responses to the encoded antigens. Instead, the immunogenicity of plasmid DNA (pDNA) requires short immunostimulatory DNA sequences (ISS) that contain a CpG dinucleotide in a particular base context. Human monocytes transfected with pDNA or double-stranded oligonucleotides containing the ISS, but not those transfected with ISS-deficient pDNA or oligonucleotides, transcribed large amounts of interferon-alpha, interferon-beta, and interleukin-12. Although ISS are necessary for gene vaccination, they down-regulate gene expression and thus may interfere with gene replacement therapy by inducing proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662521     DOI: 10.1126/science.273.5273.352

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  170 in total

Review 1.  The influence of base sequence on the immunostimulatory properties of DNA.

Authors:  D S Pisetsky
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Antiviral protection after DNA vaccination is short lived and not enhanced by CpG DNA.

Authors:  S Oehen; T Junt; C López-Macías; T A Kramps
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

3.  A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge.

Authors:  G Deliyannis; J S Boyle; J L Brady; L E Brown; A M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection.

Authors:  D M Klinman; J Conover; C Coban
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration.

Authors:  R M Cranenburgh; J A Hanak; S G Williams; D J Sherratt
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

Review 6.  Strategies for improving responses to DNA vaccines.

Authors:  J S Boyle; I G Barr; A M Lew
Journal:  Mol Med       Date:  1999-01       Impact factor: 6.354

Review 7.  Modulation of asthmatic response by immunostimulatory DNA sequences.

Authors:  D Broide; J Y Cho; M Miller; J Nayar; G Stachnick; D Castaneda; M Roman; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000

Review 8.  The response of human B lymphocytes to oligodeoxynucleotides.

Authors:  H Liang; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  2000

Review 9.  Introduction to immunostimulatory DNA sequences.

Authors:  J Van Uden; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000

Review 10.  Activation of NK cell (human and mouse) by immunostimulatory DNA sequence.

Authors:  S Yamamoto; T Yamamoto; S Iho; T Tokunaga
Journal:  Springer Semin Immunopathol       Date:  2000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.